| OAA0405 | High-throughput characterization of HIV latent reservoir demonstrates integration into genes associated with inflammation, cell cycle, and nuclear envelope assembly, enrichment in accessible chromatin, and large amounts of defective provirus | Oral abstract session with live Q&A | A16 |
| OAA0404 | Multiple sanctuary sites for intact and 'defective' HIV-1 in post-mortem tissues in individuals with suppressed HIV-1 replication: Implications for HIV-1 cure strategies | Oral abstract session with live Q&A | A16 |
| OAA0403 | Cell proliferation contributes to the increase of genetically intact HIV over time | Oral abstract session with live Q&A | A16 |
| OAA0402 | Contribution of monocytes and CD4 T cell subsets in maintaining viral reservoirs in SIV-infected macaques treated early after infection with antiretroviral drugs | Oral abstract session with live Q&A | A17 |
| OAA0307 | Co-immunization of DNA and protein in the same anatomical sites induces superior protective immune responses against SHIV challenge | Oral abstract session with live Q&A | A28 |
| OAA0306 | Protective efficacy of a vaccine inducing Gag/Vif-specific CD8+ T but not CD4+ T cells against repeated intrarectal low-dose SIVmac239 challenges | Oral abstract session with live Q&A | A27 |
| OAA0305 | Sequence and structure guided HIV-1 clade C trimeric immunogen design to induce neutralizing and V1V2 directed antibody responses | Oral abstract session with live Q&A | A25 |
| OAA0304 | Priming with DNA expressing trimeric V1V2A244 alters the immune hierarchy and favors the development of V2-specific HIV antibodies in rhesus macaques | Oral abstract session with live Q&A | A25 |
| OAA0302 | Multivariant HIV-1 infection in infants with broadly neutralizing plasma antibodies: Implication for polyvalent vaccines | Oral abstract session with live Q&A | A28 |
| OAA0206 | Gene therapy with an anti-tat gene can strongly block HIV-1 transcription and virus replication in mouse models of infection | Oral abstract session with live Q&A | A20 |